Inhibition of NF-κB sensitizes non-small cell lung cancer cells to chemotherapy-induced apoptosis

Annals of Thoracic Surgery

Volumn 70, Issue 3, 2000, Pages 930-936

  Jones, David R ^a,c   Broad, R Michael ^b   Madrid, Lee V ^b   Baldwin Jr , Albert S ^b   Mayo, Marty W ^b  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; GEMCITABINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; ANTINEOPLASTIC ANTIMETABOLITE; DEOXYCYTIDINE; DRUG DERIVATIVE;

ADVANCED CANCER; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CELL SURVIVAL; DNA BINDING; HUMAN; HUMAN CELL; LUNG NON SMALL CELL CANCER; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; CELL CULTURE; CELL DEATH; DRUG ANTAGONISM; DRUG EFFECT; LUNG TUMOR; NICK END LABELING; PATHOLOGY; PHYSIOLOGY;

ANTIMETABOLITES, ANTINEOPLASTIC; APOPTOSIS; CARCINOMA, NON-SMALL-CELL LUNG; CELL DEATH; DEOXYCYTIDINE; HUMANS; IN SITU NICK-END LABELING; LUNG NEOPLASMS; NF-KAPPA B; TUMOR CELLS, CULTURED;

EID: 0033807007     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(00)01635-0     Document Type: Article

References (27)

1. Cancer statistics 1999
2. New aspects in the staging of lung cancer: Prospective validation of the international union against cancer TNM classification
3. Surgery for stage I diseas
4. New chemotherapeutic agents prolong survival and improve quality of life in non-small cell lung cancer: A review of literature and future directions
5. Chemotherapy in non-small cell lung cancer: A meta-analysis using updated data on individual patients from 52 randomized clinical trials
6. Role of oncogenes in resistance and killing by cancer
7. TNF-and cancer therapy-induced apoptosis: Potentiation by inhibition of NF-κB
8. NF-κB antiapoptosis: Induction of TRAF1 and TRAF2 and c-IAP1 and c-1AP2 to suppress caspase-8 activation
9. The NF-κB and IκB proteins: New discoveries and insights
10. IκB proteins: Structure, function and regulation
11. Activation of NF-κB by antineoplastic agents: Role of protein kinase C
12. The role of nuclear factor-κB in cytokine gene regulation
13. Coupling of a signal response domain in I kappa B alpha to multiple pathways for NF-kappa B activation
14. Gemcitabine: A cytidine analogue active against solid tumors
15. Multiple nuclear factors interact with the immunoglobulin enhancer sequences
16. Re1/NF-κB/IκB proteins: An overview
17. Control of inducible chemoresistance: Enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-κB
18. IKK-1, and IKK-2. Cytokine-activated IκB kinases essential for NF-κB activation
19. NF-κB induces expression of the Bc1-2 homologue A1/Bfl-1 to preferentially suppress chemotherapy-induced apoptosis
20. NF-κB controls cell growth and differentiation through transcriptional regulation of cyclin D1
21. Requirement of NF-κB activation to suppress p53-independent apoptosis induced by oncogenic ras
22. Apoptosis and cancer drug targeting
23. Apoptosis: Molecular mechanisms and implications for cancer chemotherapy
24. Chemosensitivity in non-small cell lung cancer by NF-κB inhibition is Fas independent
25. Altered expression of the p50 subunit of the NF-κB transcription factor complex in non-small cell lung carcinoma
26. Innovative treatment programs against cancer: Nuclear factor-κB (NF-κB) as a molecular target
27. IκBα gene transfer is cytotoxic to squamous-cell lung cancer cells and sensitizes them to tumor necrosis factor-α-mediated cell death